ES2036181T3 - Uso de cis-n-(2-aminocicloalifatica ) benzeno acetamida y benzamida para la fabricacion de anticonvulsionantes. - Google Patents

Uso de cis-n-(2-aminocicloalifatica ) benzeno acetamida y benzamida para la fabricacion de anticonvulsionantes.

Info

Publication number
ES2036181T3
ES2036181T3 ES86906654T ES86906654T ES2036181T3 ES 2036181 T3 ES2036181 T3 ES 2036181T3 ES 86906654 T ES86906654 T ES 86906654T ES 86906654 T ES86906654 T ES 86906654T ES 2036181 T3 ES2036181 T3 ES 2036181T3
Authority
ES
Spain
Prior art keywords
manufacture
cis
aminocicloalifatica
seizures
benzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86906654T
Other languages
English (en)
Inventor
Jacob Szmuszkovicz
Voigtlander Philip F. Von
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ES2036181T3 publication Critical patent/ES2036181T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

USO DE CIS-N-(2-AMINOCICLOALIFATICA ) BENZENO ACETAMIDA Y BENZAMIDA PARA LA FABRICACION DE ANTICONVULSIONANTES. Uso de un compuesto para la manufactura de un medicamento para prevenir o tratar ataques contra el sistema nervioso central, en que el compuesto es de la fórmula I **fórmula** en que los circulos rellenados indican que los dos átomos de nitrógeno están en la orientación cis; n es1ó 2; m es0ó 1; R eshidrógeno o C1-3 alquilo; cualesquiera de R1 y R2 son iguales o diferentes grupos C1-3 alquilo, o NR1R2 es 1 - pirrolidinilo; y cualesquiera de X e Y están independientemente seleccionados de H, F, Br y Cl, o X es H e Y es CF3; o es una de sus sales farmaceuticamente aceptables. (Reserva del art. 167.2 CPE).
ES86906654T 1985-10-25 1986-10-21 Uso de cis-n-(2-aminocicloalifatica ) benzeno acetamida y benzamida para la fabricacion de anticonvulsionantes. Expired - Lifetime ES2036181T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79131185A 1985-10-25 1985-10-25

Publications (1)

Publication Number Publication Date
ES2036181T3 true ES2036181T3 (es) 1993-05-16

Family

ID=25153322

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86906654T Expired - Lifetime ES2036181T3 (es) 1985-10-25 1986-10-21 Uso de cis-n-(2-aminocicloalifatica ) benzeno acetamida y benzamida para la fabricacion de anticonvulsionantes.

Country Status (5)

Country Link
EP (2) EP0222533A1 (es)
JP (1) JPS63501152A (es)
DE (1) DE3668268D1 (es)
ES (1) ES2036181T3 (es)
WO (1) WO1987002584A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674849B1 (fr) * 1991-04-02 1994-12-23 Logeais Labor Jacques Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
FR2766486B1 (fr) * 1997-07-25 1999-09-17 Logeais Labor Jacques Cycloalkyles benzamides stimulants de la motricite gastrointestinale haute et basse
FR2766484B1 (fr) * 1997-07-25 1999-09-17 Logeais Labor Jacques Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse
EP1422217A3 (en) 1998-04-01 2004-06-16 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
US7053087B1 (en) 1999-03-04 2006-05-30 Cardiome Pharma Corp. Aminocycloalkyl cinnamide compounds for arrhythmia and analgesics and anesthetics
US7507545B2 (en) 1999-03-31 2009-03-24 Cardiome Pharma Corp. Ion channel modulating activity method
US7524879B2 (en) 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7057053B2 (en) 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
KR101059379B1 (ko) 2003-05-02 2011-08-26 카디오메 파마 코포레이션 아미노사이클로헥실 에테르 화합물, 이의 제조방법 및 이를 포함하는 약제학적 조성물
US7345086B2 (en) 2003-05-02 2008-03-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
US7674820B2 (en) 2003-08-07 2010-03-09 Cardiome Pharma Corp. Ion channel modulating activity I
US7345087B2 (en) 2003-10-31 2008-03-18 Cardiome Pharma Corp. Aminocyclohexyl ether compounds and uses thereof
US8058304B2 (en) 2004-04-01 2011-11-15 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
US7977373B2 (en) 2004-04-01 2011-07-12 Cardiome Pharma Corp. Prodrugs of ion channel modulating compounds and uses thereof
US8263638B2 (en) 2004-11-08 2012-09-11 Cardiome Pharma Corp. Dosing regimens for ion channel modulating compounds
US8080541B2 (en) * 2009-08-27 2011-12-20 Hoffman-La Roche Inc. Carbocyclic GlyT-1 receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4098904A (en) * 1976-11-12 1978-07-04 The Upjohn Company Analgesic n-(2-aminocycloaliphatic)benzamides
US4145435A (en) * 1976-11-12 1979-03-20 The Upjohn Company 2-aminocycloaliphatic amide compounds
US4463013A (en) * 1982-04-09 1984-07-31 The Upjohn Company Oxygen substituted amino-cyclohexyl-benzeneacetamides and -benzamides as water diuretic drugs

Also Published As

Publication number Publication date
JPS63501152A (ja) 1988-04-28
EP0248824A1 (en) 1987-12-16
WO1987002584A1 (en) 1987-05-07
EP0248824B1 (en) 1990-01-17
DE3668268D1 (de) 1990-02-22
EP0222533A1 (en) 1987-05-20

Similar Documents

Publication Publication Date Title
DK0527687T3 (da) Hidtil ukendte arylethylaminderivater, fremgansmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
HUT73417A (en) Enniatines and enniatine derivatives used to control endoparasites
ES2146791T3 (es) Compuestos bifenilicos sustituidos para el tratamiento de la inflamacion.
MX9207495A (es) Compuestos de tetrahidroisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR016001A1 (es) Uso de polimeros de amina alifatica para la fabricacion de medicamentos para la reduccion de niveles de oxalato en un paciente
ES2084944T3 (es) Amidas terapeuticas.
ES2150577T3 (es) Aminoeteres aromaticos como agentes para aliviar el dolor.
ES2096150T3 (es) Copolimeros vinilicos reticulados, procedimiento para su preparacion, asi como el empleo de estos compuestos.
MX9205681A (es) Aminometil-cromanos, procedimiento para su fabricacion y medicamento que los contiene.
ES2114931T3 (es) Nuevos esteres esteroidales.
ES2178676T3 (es) Compuestos de pirimidina substituidos y su empleo.
ES2153420T3 (es) Derivados de amida biciclica y uso como relajantes musculares de los mismos.
MX9300616A (es) Compuestos antagonistas del receptor 5-hidroxitriptamina, proceso para su prepararcion y composicion farmaceutica que los contiene
ES2058596T3 (es) Empleo de derivados de l-carnitina en el tratamiento terapeutico de alteraciones degenerativas del sistema nervioso.
ES2128043T3 (es) Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral.
ES2134472T3 (es) Derivados de amida y su uso terapeutico.
ES2040201T3 (es) Acidos 3-piperidin- o 3-piridin-carboxilicos n-sustituidos y sus derivados.
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
EE9800141A (et) Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
AR008244A1 (es) Compuestos heterociclicos, procedimiento para prepararlos, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
ES2131300T3 (es) Derivados triciclicos y composiciones farmaceuticas que los contienen.
ATE39482T1 (de) N-(1-ethyl-2-pyrrolidinylmethyl)-benzamidderivate, verfahren und zwischenprodukte zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
ES2052776T3 (es) Derivados o-alcanoilo del acido 3-amino-2-hidroxipropansulfonico con actividad anticonvulsiva y composiciones farmaceuticas que los contienen para el tratamiento terapeutico de epilepsia.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 248824

Country of ref document: ES